|Articles|September 1, 2001
Eflornithine cream favorably alters PFB
Washington - Results from a small exploratory translational research study suggest that eflornithine hydrochloride (HCl) 13.9 percent cream (Vaniqa) may be an effective treatment for pseudofolliculitis barbae, University of Minnesota researchers reported at the annual meeting of the Society for Investigative Dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Christopher Bunick, MD, PhD, on Expanding Targets in Inflammatory Skin Disease
2
GLP-1s and Skin Health: Clinical Pearls From Gold and Lal
3
When Innovation Meets Insurance Barriers With Lisa Swanson, MD
4
Mona Shahriari, MD, FAAD, on OX40-Targeted Therapy in AD
5






